Immunohistochemistry in diagnostic neuropathology - Limitations and interpretations

Folia Neuropathologica

Volumn 37, Issue 3, 1999, Pages 128-130

  Kordek, Radzisław ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Brain tumors; Immunohistochemistiy; Interpretation

Indexed keywords

BIOLOGICAL MARKER; CANCER ANTIBODY; TUMOR ANTIGEN;

ARTICLE; BRAIN TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 0033258360     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Burger PC, Scheithauer BW: Tumors of the central nervous system. Washington, DC, Armed Forces Institute of Pathology, 1994.
2. Bonetii F, Colombari R, Manfrin E, Zamboni G, Martignani G, Mombello A, Chilosi M: : Breast carcinoma with positive results for melanoma marker (HMB-45); HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol, 1989, 92, 491-495.
3. Drier JK, Swanson PE, Cherwitz DL, Wick MR: S100 protein immunoreactivity in poorly differentiated carcinomas; immunohistochemical comparison with malignant melanoma. Arch Pathol Lab Med, 1987, 111, 447-452.
4. Miettinen M, Franssila K: Immunohistochemicalspectrum of malignant melanoma; the common presence of keratins. Lab Invest, 1989, 61, 623-628.
5. Mossakowski MJ, Liberski PP: Tumors of the central nervous system, (in Polish). Ossolineum, Wrocław, 1997
6. Quinn B: Synaptophysin staining in normal brain. Importance for diagnosis of ganglioglioma. Am J Surg Pathol, 1998, 22, 550-556.